Screener
Gyre Therapeutics, Inc. GYRE Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $43.29M+18.6% | $37.5M+149% | $49.19M+316% | $40.4M+155% | $36.49M+127% | ||
| $14.06M-21.3% | $12.31M-17.1% | $15.36M+3.3% | $19.65M+113% | $17.87M+98.5% | ||
| $27.76M+12.7% | $22.76M+13.0% | $31.08M+58.7% | $25.88M+32.8% | $24.63M+32.3% | ||
| $11.43M+29.0% | $11.35M+44.1% | $10.17M+60.5% | $8.85M+38.8% | $8.86M+57.2% | ||
| $122.07M+33.7% | $91.73M+34.0% | $149.36M+131% | $98.58M+79.9% | $91.29M+70.6% | ||
| $27.28M+16.6% | $23.57M+0.2% | $27.55M+15.4% | $23.61M-3.4% | $23.4M-1.1% | ||
| $4.53M-8.8% | $4.63M-9.0% | $4.73M+1,632% | $4.85M+2,534% | $4.96M+2,568% | ||
| $199.26M+30.5% | $162.02M+24.8% | $219.76M+75.2% | $159.38M+27.3% | $152.65M+26.2% | ||
| $1.24M+1,641% | $265K+117% | $1.34M+1,136% | $556K+83.5% | $71K-73.8% | ||
| $829K— | $840K+2,900% | $14K-77.0% | $58K-68.6% | $0-100% | ||
| $28.66M+69.4% | $19.79M+4.2% | $23.78M+21.9% | $15.91M+8.1% | $16.92M+8.6% | ||
| $34.34M+48.0% | $25.03M-1.8% | $31.4M+16.3% | $21.97M-17.9% | $23.2M-15.9% | ||
| $106K+16.5% | $91K+4.6% | $91K+5.8% | $91K+7.1% | $91K+7.1% | ||
| -$137.96M-96.2% | -$77.67M-9.8% | -$112.6M-53.3% | -$66.7M+9.1% | -$70.31M+5.6% | ||
| $107.93M+17.3% | $101.31M+48.7% | $62.5M-1.3% | $101.92M+61.3% | $92.03M+52.5% | ||
| $199.26M+30.5% | $162.02M+24.8% | $219.76M+75.2% | $159.38M+27.3% | $152.65M+26.2% |
FAQ
- What are Gyre Therapeutics, Inc.'s total assets?
- Gyre Therapeutics, Inc. (GYRE) holds $199.3M in total assets, up 30.5% year over year.
- How much debt does Gyre Therapeutics, Inc. have?
- Gyre Therapeutics, Inc. carries $3.4M in total debt against $107.9M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Gyre Therapeutics, Inc. have?
- Gyre Therapeutics, Inc. holds $43.3M in cash and equivalents.
- Can Gyre Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 4.26 — current assets exceed current liabilities.
- Where does Gyre Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Gyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
